Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | APLNR | P35414 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11536710 | 0.85 | DAO (0.46) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL11335697 | 0.76 | NPC1 (0.40) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL11335709 | 0.76 | NPC1 (0.40) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL6932293 | 0.75 | TSHR (0.44) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL9558280 | 0.74 | NPC1 (0.58) | L3MBTL1ALDH1A1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL11556578 | 0.72 | DAO (0.39) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL11556580 | 0.72 | DAO (0.39) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL1233245 | 0.72 | CES2 (0.65) | L3MBTL1ALDH1A1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL6935492 | 0.71 | TDP1 (0.46) | ALDH1A1KMT2ASMN1; SMN2MAPTHDAC1 | |
| SCHEMBL6932501 | 0.71 | PKM (0.47) | L3MBTL1ALDH1A1KMT2ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1200393-B1 | OXIME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY | MONSANTO TECHNOLOGY LLC (US) | 2003-12-10 | — | — | EP | disclosed |
| EP-1200393-A1 | OXIME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY | Monsanto Technology LLC (US) | 2002-05-02 | — | — | EP | disclosed |
| US-20020045655-A1 | Oxime amides and hydrazone amides having fungicidal activity | MONSANTO TECHNOLOGY LLC. | 2002-04-18 | — | — | US | disclosed |
| US-6359156-B1 | CONTROLLING DISEASES IN CEREAL PLANTS | MONSANTO TECHNOLOGY LLC | 2002-03-19 | — | — | US | disclosed |
| US-6297271-B1 | CONTROLLING TAKE-ALL DISEASE IN A PLANT | MONSANTO TECHNOLOGY LLC | 2001-10-02 | — | — | US | disclosed |
| WO-2001012590-A1 | OXYME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY | MONSANTO TECHNOLOGY LLC (US) | 2001-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045655-A1 | Oxime amides and hydrazone amides having fungicidal activity | AADAC, HAAO, OGA | L3MBTL1 1936/4885ALDH1A1 1260/4885KMT2A 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.